Alpha Profiles · Company Profile

MADRIGAL PHARMACEUTICALS, INC.

Canonical company identity and public leadership record.

https://registry.alpha.ac/companies/madrigal-pharmaceuticals-inc

Entity: Public listing published
Primary listing: NASDAQ: MDGL
Verification: Partially verified
Last reviewed: 2026-09-12T21:30:58.287972+00:00

Overview

Alpha's canonical identity and public leadership record for MADRIGAL PHARMACEUTICALS, INC..

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

7 public records

Bill Sibold

President and Chief Executive Officer

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: MDGL executive roster sourceMay 3, 2026

Carole Huntsman

Executive Vice President and Chief Commercial Officer

State: confirmed
Effective: From Apr 28, 2026
Confidence: 94%
Evidence: MDGL DEF 14A executive officersApr 28, 2026

David Soergel

Executive Vice President and Chief Medical Officer

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: MDGL executive roster sourceMay 3, 2026

David Soergel, M.D.

Executive Vice President and Chief Medical Officer

State: confirmed
Effective: From Apr 28, 2026
Confidence: 94%
Evidence: MDGL DEF 14A executive officersApr 28, 2026

Mardi Dier

Executive Vice President and Chief Financial Officer

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: MDGL executive roster sourceMay 3, 2026

Shannon Kelley

Executive Vice President and Chief Legal Counsel

State: confirmed
Effective: From Apr 28, 2026
Confidence: 94%
Evidence: MDGL DEF 14A executive officersApr 28, 2026

Stephen D. Kelley

Executive Vice President and Chief Legal Counsel

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: MDGL executive roster sourceMay 3, 2026

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Sep 12, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.